secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inogen Inc (INGN)
CIK:        0001294133
Form:       8-K
Filed at:   2022-12-22T23:59:59+00:00
Accession:  0000950170-22-026958
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 2.05
LLM model:  deepseek-v4-flash:cloud@v2

Inogen abandons TAV ventilator program, expects $53.4M asset write-down in Q4 2022
--------------------------------------------------------------------------------

- Ceased development of TAV technology from New Aera; estimates $53.4M loss on disposal of intangible assets.
- Loss on inventory of $0.2-$0.3M, partially offset by $13.6-$13.7M decrease in earnout liability.
- No significant future cash charges expected; disposal to be completed by Dec 31, 2022.
- Decision based on lack of product compatibility, no Medicare reimbursement, and substantial additional investment needed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1294133/000095017022026958/0000950170-22-026958-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1294133/000095017022026958/ingn-20221219.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-026958

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer